Omentin-1 vs Ipamorelin
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Ipamorelin (Growth Hormone Secretagogue) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Omentin-1 | Ipamorelin |
|---|---|---|
| Category | Diabetes & Metabolic | Performance |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Growth Hormone Secretagogue |
| Molecular Weight | ~35 kDa | 711.85 Da |
| Half-Life | hours | ~2 hours |
| Amino Acids | 313 | 5 |
| Typical Dose | No approved human dose; research use only | 200-300 mcg |
| Route | IV|SC | SC |
| Purity | ≥98% | — |
| Studies Count | 82 | 156 |
| Research Status | Pre-clinical | Clinical Trials |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Ipamorelin Benefits
- ✓Stimulates natural GH release
- ✓Minimal cortisol/prolactin increase
- ✓Improved body composition
- ✓Enhanced recovery and sleep quality
- ✓Anti-aging effects
Omentin-1 Dosing
not established|not established
Ipamorelin Dosing
Standard: 200-300 mcg SC 2-3 times daily|Pre-bed: 200 mcg SC 30 min before sleep|Combined: 100-200 mcg with CJC-1295 2-3x daily
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Ipamorelin Side Effects
- ⚠Common (Mild): Temporary tingling, water retention, increased appetite
- ⚠Rare: Headache, lightheadedness
- ⚠Very Well Tolerated overall
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Ipamorelin
Ipamorelin has moderate clinical evidence. Phase II trials demonstrate selective GH release. Generally regarded as one of the safest GH secretagogues with minimal side effect profile.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.